生物医药产业一直是全国各地争相布局的重要产业赛道,深圳“十四五”规划提出建设生物医药强市的战略目标。深圳生物医药产业发展以2020年为重要节点。2020年之前全市生物医药产业一直存在产业结构失衡、产业集聚程度不高、产业投资前端布局不足等问题;2020年以来,全市密集出台一系列生物医药产业扶持政策,对产业准入、产业链布局以及各区产业特色发展等做出针对性的规划和指导,探索出一条具有深圳特色的产业发展路径。深圳的经验表明,发展生物医药产业一定要明确政府和市场主体定位,强化产业链、创新链、人才链、资金链的链接,平衡好区域合作与区域特色发展。
<<Biomedicine has always been an important industrial track competing by the areas across China. Shenzhen’s “14th Five-Year Plan” puts forward the strategic goal of building a strong biomedical city. 2020 is set to be the important node of Shenzhen’s biomedical industry. Before 2020,the city’s biomedical industry suffered from the problems such us the imbalance in the industrial structure,shortage of industrial agglomeration,insufficient industrial investment front-end layout etc. Since 2020,Shenzhen has intensively introduced a series of support policies on the biomedical industry,providing the targeted planning and guidance to explore an industrial development path with Shenzhen characteristics. Shenzhen’s experience shows that the development of the biomedical industry must clarify the positioning of the government and market entities,strengthen the link between the industrial chain,the innovation chain,the talent chain,the capital chain,and the balance between regional cooperation and regional characteristics.
<<